Sobi completes acquisition of Arthrosi Therapeutics, strengthening pipeline for the potential treatment of gout
PR Newswire —
STOCKHOLM, Feb. 9, 2026 /PRNewswire/ -- Swedish Orphan Biovitrum AB (publ) Sobi® (STO: SOBI) and Arthrosi Therapeutics, Inc. (Arthrosi) announced today the completion of the acquisition of Arthrosi by Sobi. Upon completion of the transaction, Sobi has acquired all outstanding shares of...